Detalhe da pesquisa
1.
Epigenetic state determines inflammatory sensing in neuroblastoma.
Proc Natl Acad Sci U S A
; 119(6)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121657
2.
Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.
J Pathol
; 257(3): 327-339, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254670
3.
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
BMC Cancer
; 22(1): 669, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715791
4.
Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.
J Pathol Clin Res
; 9(1): 32-43, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148636
5.
Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
Biochem Pharmacol
; 208: 115408, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603685
6.
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460335
7.
SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.
J Control Release
; 342: 81-92, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974029
8.
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma.
Cancer Discov
; 12(12): 2800-2819, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108156
9.
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.
Cancer Cell
; 40(1): 53-69.e9, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971569
10.
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.
Oncogene
; 40(39): 5843-5853, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345016
11.
Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
J Pathol Clin Res
; 7(4): 338-349, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837665
12.
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Nat Commun
; 12(1): 5578, 2021 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552068
13.
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution.
J Control Release
; 324: 440-449, 2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497782
14.
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.
Sci Transl Med
; 11(476)2019 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674657
15.
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas.
J Control Release
; 276: 59-71, 2018 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501533
16.
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma.
Oncotarget
; 9(59): 31397-31410, 2018 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30140378
17.
Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber Matrices.
Adv Healthc Mater
; 7(15): e1800255, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892999
18.
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
J Control Release
; 264: 34-44, 2017 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830790
19.
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8.
J Control Release
; 255: 108-119, 2017 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412222
20.
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery.
Biomaterials
; 79: 69-78, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695118